William Blair Downgrades RayzeBio to Market Perform
Portfolio Pulse from Benzinga Newsdesk
William Blair analyst Andy Hsieh has downgraded RayzeBio (NASDAQ:RYZB) from Outperform to Market Perform, indicating a change in the firm's outlook on the company's stock.
December 26, 2023 | 3:41 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
RayzeBio has been downgraded by William Blair from Outperform to Market Perform, which may influence investors' perception and could potentially affect the stock's performance in the short term.
Downgrades by analysts, such as the one from William Blair for RayzeBio, can lead to a negative perception among investors and a possible decrease in stock price in the short term as market sentiment adjusts to the new rating.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100